glp-1 downsides Why Drugs Alone Aren't Enough for Sustainable Weight Loss – STAAR LABS Starting a GLP-1 medication? Knowing

HD: Conceptualization, Methodology, Project administration, Writing original draft

doi:10.1093/oxfordjournals.humrep.a019708 Lenzi A, Lombardo F, Gandini L, Culasso F, Dondero F

Theranostics 11 , 30523059 (2021)

Strategic Assessment Lilly is building the broadest range of options in terms of both route of administration and mechanism of action, combining approved dual-agonist injections, approved oral small molecules, and triple agonists currently in development

(33896531) Phenytoin accumulation, as well as an increased free fraction of phenytoin, may tend to cause phenytoin toxicity

This remains an active area of clinical observation rather than established fact from controlled trials